Frontlight ResearchEarly access
Trial site
Chattanooga Research & Medicine, PLLC
- 1running trial
- 4closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease1 trial
- COPD1 trial
- Familial hypercholesterolaemia1 trial
- Obesity1 trial
- Phase
- Phase 34 trials
- Phase 21 trial
- Status
- Completed4 trials
- Active, not recruiting1 trial
- Lead sponsor
- Ionis Pharmaceuticals, Inc.2 trials
- Boehringer Ingelheim1 trial
- NewAmsterdam Pharma1 trial
- Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA1 trial
Running trials
Closed trials
Completed
Completed
Completed
Completed
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
Site data: ClinicalTrials.govUpdated 17 Nov 2026